2050 Article Views
Publication Date: 26 Mar 2008
Journal: Clinical Medicine Insights: Cardiology Clinical Medicine: Cardiology 2008:2 103-105
Abstract Allison G. Dupont and Mauricio G. Cohen
Division of Cardiology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Abstract
5-Fluorouracil (5-FU) is a chemotherapeutic agent commonly used to treat various malignancies. Cardiotoxicity is a rare adverse effect in patients being treated with 5-FU, but it can be severe and even fatal. The mechanism of myocardial ischemia caused by 5-FU is not known but several hypotheses exist, of which coronary vasospasm is the most widely accepted. Importantly, patients with preexisting coronary artery disease have been shown to be at increased risk of developing myocardial ischemia secondary to 5-FU. We present a case of 5-FU-induced chest pain and ST segment elevation in a patient with pre-existing coronary artery disease. The aim of this article is to provide a brief review of the available literature surrounding the topic of 5-FU cardiotoxicity and to heighten the readers’ awareness of the potential adverse cardiac effects of this agent.
Discussion
No comments yet...Be the first to comment.
My experience with Libertas Academica was great. The manuscript review, editing and publication process was easy and smooth and the support staff were great to work with. Overall a great experience.Assistant Professor Michael J Burke MD (University of Minnesota, Minneapolis, MN, USA) What our authors say
Copyright © 2010 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)